Here are five things to know:
1. Under the private-label agreement, Innovasis will receive Stability Biologics’ private labeled bone allograft tissue products, including its flagship product, Physio.
2. Physio a physiologic bone tissue allograft made of donated human tissue, with no added extrinsic carrier.
3. Innovasis Director of Business Development and Clinical Affairs David Oka said, “We anticipate Physio’s differentiated osteogenic microstructure will provide a potent ecosystem when used with our PEEK-Optima HA Enhanced interbody platform.”
4. Innovasis expects to commercialize its private-labeled product lines by December.
5. Stability Biologics provides human allograft tissue products for spine, orthopedic and wound care applications.
More articles on biologics:
FDA warns biologics company about illegally manufacturing stem cell products: 5 insights
4 things to know about CollPlant
SpinalCyte’s CybroCell injections led to sustained improvement in clinical study: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.